Editorial: NSAIDs Pharmacogenomics.

Creator(s)

José A G Agúndez
Christine Formea
Andrea Gaedigk, Children' Mercy Kansas CityFollow
Elena García-Martín
Li Gong
Tilo Grosser
Craig R. Lee
Katherine N. Theken

Document Type

Editorial

Publication Date

11-19-2021

Identifier

DOI: 10.3389/fphar.2021.798447; PMCID: PMC8640121

Journal Title

Front Pharmacol

Volume

12

First Page

798447

Last Page

798447

Keywords

adverse drug effects; non-steroidal anti-inflammatory drug (NSAID); pharmacodynamic (PD); pharmacogenomics (PGx); pharmacokinectics & drug metabolism (PDM)

Comments

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Publisher's Link: https://www.frontiersin.org/articles/10.3389/fphar.2021.798447/full

Recommended Citation

Agúndez JAG, Formea C, Gaedigk A, García-Martín E, Gong L, Grosser T, Lee CR, Theken KN. Editorial: NSAIDs Pharmacogenomics. Front Pharmacol. 2021 Nov 19;12:798447. doi: 10.3389/fphar.2021.798447. PMID: 34867430; PMCID: PMC8640121.